Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRISPR
Biotech
Intellia, Alnylam post data on contrasting cardiomyopathy ideas
Intellia and Alnylam post rivaling CRISPR/RNAi data drops.
Nick Paul Taylor
Nov 18, 2024 7:40am
Beam hits hemoglobin goal in first base editing clinical data
Nov 5, 2024 9:00am
Spanish gene editor licenses DNA-cutting enzymes for up to $43M
Nov 4, 2024 1:46pm
Intellia links in vivo CRISPR therapy to 81% drop in HAE attacks
Oct 24, 2024 8:55am
CRISPR gene therapy for deafness works in young adult mice
Jul 11, 2024 9:15am
Bridge RNA from 'jumping genes' could overcome CRISPR limits
Jul 1, 2024 6:55am